Legacy MEDSearch

JUNE 27, 2022

Centerline), a private medical technology company, announced the closing of a $33 million Series B equity financing led by Cleveland Clinic with participation by GE Healthcare, RIK Enterprises, JobsOhio, Jumpstart Ventures and G2 Group Ventures. IOPS® is FDA 510(k) cleared and currently launching in the US at select sites.

Recruitment 52

Recruitment Healthcare Healthcare Safety 52

Pharmaceutical Technology

OCTOBER 5, 2022

In 2009, former Biogen employee Michael Bawduniak filed a lawsuit claiming that Biogen had violated the False Claims Act and the Anti-Kickback Statute by providing millions of dollars to healthcare providers (HCPs) as an incentive to prescribe three of its multiple sclerosis (MS) drugs. 4 integrins, which play a key role in MS pathology.

Government 59

Government Specialization Physicians Education 59

pharmaphorum

SEPTEMBER 27, 2022

The suit claimed that Biogen paid millions of dollars to doctors in the form of speaker honoraria, training fees, consulting fees, and meals to induce them to prescribe the MS drugs Avonex (interferon-beta-1a), Tysabri (natalizumab), and Tecfidera (dimethyl fumarate) between 2009 and 2014.

Government 44

Government Doctors Consulting Training 44

European Pharmaceutical Review

DECEMBER 21, 2022

This US pathway offers early-phase benefits, including greater FDA collaboration. This US pathway is usually leveraged at later stages in drug development and permits sponsors to use surrogate endpoints to get faster FDA approval. Medicines and Healthcare products Regulatory Agency. Breakthrough therapy designation.

Food and Drug Administration 109

Food and Drug Administration Medicine Food Government 109

European Pharmaceutical Review

AUGUST 23, 2022

The US Food and Drug Administration (FDA) further estimates that 97 percent of online pharmacies are operating illegally. We hope that this article serves draws attention from the community and makes funding agencies aware of this imperative healthcare sustainability problem. About the author. Available from: [link]. 2022;8(5):513-26.

Medicine 92

Medicine Food and Drug Administration Pharmaceutical products Pharmaceutical 92

European Pharmaceutical Review

JUNE 27, 2023

Of note, the US Food and Drug Administration (FDA) and ANSM (French regulatory authorities) have established themselves as early leaders to develop guidelines. Since these fresh FDA approvals for microbiome-based therapies, regulatory pathways are becoming clearer and opening new perspectives for companies.

Food and Drug Administration 99

Food and Drug Administration Manufacturing Medicine Pharma 99

European Pharmaceutical Review

JULY 13, 2023

1,2 Moreover, except for countries such as Czechia, Denmark and Germany, the cost of these medications is borne by the patient, rather than national insurance or healthcare systems. It is estimated that only one in 10 drugs that enter Phase I trials are subsequently licensed by the US Food and Drug Administration (FDA).

Medical 86

Medical Food and Drug Administration Pharmacology Medicine 86

Evolve Your Success

JUNE 28, 2022

This was from 2008 to 2014. By 2014, we were on our way with Providence. In 2014, it was clear that Thayer was going to be hard. We got a couple of our products FDA cleared and we raised our first venture financing. That’s the fun part about healthcare innovation. It had a term sheet and it was going to be great.

Sales 52

Sales Pharma Medical sales reps Medical sales 52

pharmaphorum

OCTOBER 26, 2022

We promptly discussed this need with the FDA and the agency agreed to a proposed amendment of the protocol to accommodate, in a safe manner, the patient access to the EAP.”. These groups have also used patient feedback to build digital tools to help facilitate engagement. Chiesi’s philosophy in action.

Patients 79

Patients Pharma Consulting Transportation 79

European Pharmaceutical Review

FEBRUARY 22, 2023

Of the 175 new drugs approved by the US Food and Drug Administration (FDA) between 2016 and 2019, most were biologics. He has been a key member of the executive team, most recently serving as the company’s Vice President, Strategy since 2014. Biologics represent an increasingly large part of the pharmaceutical industry.

Food and Drug Administration 90

Food and Drug Administration Manufacturing Safety Pharmaceutical 90

Evolve Your Success

JANUARY 23, 2024

The negotiation with the hospital, the shipping across boundaries, frontiers, FDA, and non-FDA is very interesting. It’s very interesting, all the way to the surgical procedure, the recovery, and to 2 or 3 years later, which is the patient record and outcome tracking. It’s a very interesting business. This is it.

Medical sales 52

Medical sales Medical Sales Physicians 52

Legacy MEDSearch

OCTOBER 6, 2022

.” “As global economic growth slows, healthcare institutions everywhere are increasingly looking at how to enable their existing medical staff to deliver superior clinical outcomes and patient experience at a lower cost,” said David Webster, CEO of Body Vision Medical. About Body Vision Medical.

Consulting 52

Consulting Medical Recruitment Marketing 52

Pharmaceutical Technology

MAY 26, 2023

The FDA has flagged this issue as pharmacies selling prescription drugs illegally have proliferated over the years. The US Food and Drug Administration (FDA commissioner Dr. Robert Califf says, “The illegal sale of prescription drug stimulants online puts Americans at risk and contributes to potential abuse, misuse, and overdose.”

Food and Drug Administration 52

Food and Drug Administration Prescription FDA Medical 52

Pharmaceutical Technology

JANUARY 6, 2023

The agreement outlined that Par would keep its generic equivalent off the market for as many as two years, delaying the generic launch till September 30, 2014. In September, Novartis sent the FDA a petition, after a similar one was rejected in April 2021, asking for Entresto’s patent protection to be extended to February 2024.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

Pharmaceutical Technology

NOVEMBER 30, 2022

In October, the US FDA granted Eli Lilly’s Mounjaro (tirzepatide) a Fast Track designation for its use as a treatment for obesity. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually. NICE has only allowed healthcare providers to prescribe continuous treatment of the drug for two years.

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

In October, the US FDA granted Eli Lilly’s Mounjaro (tirzepatide) a Fast Track designation for its use as a treatment for obesity. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually. NICE has only allowed healthcare providers to prescribe continuous treatment of the drug for two years.

Medical 98

Medical Manufacturing Insurance Side effects 98

Pharmaceutical Technology

FEBRUARY 6, 2023

The FDA approved both drugs in 2014. On February 2, the FDA cleared an Investigational New Drug Application for PLN-101095. The standard treatments for IPF include Esbriet ( pirfenidone ) which is marketed by Genentech, a part of Roche, and Boehringer Ingelheim’s Ofev ( nintedanib), which are used to slow disease progression.

Marketing 59

Marketing Pharmaceutical FDA Prospecting 59